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Modelling the amino acid sequence of NAD’-linked 15-hydroxyprostaglandin dehydrogenase into the three-dimensional structure of 3a/20B- 
hydroxysteroid ehydrogenase shows that these two enzymes, as well as the NADP’-linked prostaglandin dehydrogenase (identical to carbonyl 
reductase) have similar conformations, in spite of very limited sequence identity (23-288). Conservation of tertiary structures is greatest over the 
first two thirds of the polypeptide chains, where the typical NAD’ binding fold is retained, including the five first B-strands, with only two short 
deletions or insertions up to residue 147. The remaining thirds of each of the prostaglandin dehydrogenases have significantly different architecture, 
including insertions that may contribute to enzyme specificity, and, except for an additional helix (aG), are difficult to model. Active site 
relationships can be evaluated and subunit interactions predicted, suggesting that the aE + aF two-helix surface constitutes the major subunit 
interacting area, forming a dimeric unit in the oligomeric enzymes. 
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1. INTRODUCTION 
Two different cytosolic types of human prostaglandin 
dehydrogenase have been characterized, a monomeric 
NADP’-linked enzyme identical to carbonyl reductase 
[l-4], and a dimeric NAD’-linked enzyme [5]. Both 
belong to the short-chain dehydrogenase family, but 
they are highly divergent, exhibiting identical residues 
at the 20% level [1,2,6]. The tertiary structures of other 
members of this family, a tetrameric steroid dehydroge- 
nase and a dimeric dihydropteridine reductase [7,8], 
have recently been crystallographically determined, and 
a model for NADP’-linked prostaglandin dehydroge- 
nase has been based upon these studies [11. Although the 
model has a closely related conformation, it has several 
features not present in the observed structures, includ- 
ing elements of secondary structure, and a partly shifted 
architecture. However, all members of the short-chain 
dehydrogenase family are peculiar in having a single 
domain, with more (and a few longer) strands in the 
p-pleated sheet [1,7,8] than those found in correspond- 
ing parts of the medium-chain dehydrogenases [9]. 
Because of the low degree of homology, the confor- 
mation of the other prostaglandin dehydrogenase isalso 
of interest, he NAD’-linked enzyme from human placenta. 
In the present work, we compare by computer graphics 
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the NAD’-linked enzyme with the crystallographically 
analyzed steroid dehydrogenase [7], and relate the two 
prostaglandin dehydrogenases to each other. 
2. MATERIALS AND METHODS 
2.1. Sequence alignment 
The sequences of human placental NAD’-linked 15-hydroxy- 
prostaglandin dehydrogenase [5] and 3cr/20fi-hydroxysteroid dehydro- 
genase from Streptomyces hydrogenans [IO] were aligned using the 
program ALIGN [1 1] to maximize sequence identity between the two 
proteins. The alignment was then adjusted manually in order to con- 
serve secondary structure. This was performed by shifting, where 
possible, computer-generated insertions and deletions from inside ele- 
ments of secondary structure into the closest loop regions, if they had 
not already originally been introduced at such places. 
2.2. Model building 
The model of NAD’-linked 15-hydroxyprostaglandin dehydroge- 
nase was built on an Evans and Sutherland PS 390 computer graphics 
system with the FRODO program [13,14] based on the coordinates of 
3u/20/?-hydroxysteroid dehydrogenase [7]. The amino acid sequence 
of 15-hydroxyprostaglandin dehydrogenase was transferred into the 
model by replacement and refinement of amino acids in groups of five 
residues. The torsion angles of the side-chains were adjusted to avoid 
unfavourable contacts with other side-chains. The model was energy 
minimized using the program XPLOR [15] that refined the positional 
parameters of the dimeric atoms. The energy minimization process 
converged after 200 cycles of refinement. The van der Waals and 
Electric energies were -2,382 kcahmol and -7,585 kcal/mol, respec- 
tively. The bond distance, bond angle, and dihedral angle energies 
were 200 kcal/mol, 743 kcal/mol, and 533 kcal/mol, respectively. The 
two-fold rotational symmetry restraining energy between the subunits 
was 2 kcal/mol. 
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Two short insertions in the prostaglandin dehydrogenase r lative to 
the steroid dehydrogenase had to be modelled. An insertion of five 
residues at the end of aC could be accommodated by extension of the 
a-helix by one residue, and modelling of the additional four residues 
into the loop connecting aC with/W. The other insertion, two residues 
at the end of aF, was modelled as an extension of the loop between 
aF and /?F. A deletion of five residues at the end of aE was modelled 
by elimination of these residues from the end of the helix, leaving aE 
1.5 turns shorter, but with similar end connections. Two segments of 
1Shydroxyprostaglandin dehydrogenase, Ile’90-Pro2z2 and L~s*~~- 
Glu*“, are not included in the model, because of too extensive differ- 
ences in those parts. 
3. RESULTS AND DISCUSSION 
3.1. Alignment 
The alignment now obtained between the NAD’- 
linked 15hydroxyprostaglandin dehydrogenase and 
corresponding parts of 3a./20JI-hydroxysteroid ehy- 
drogenase is shown in Fig. 1. Overall, the residue iden- 
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tity is 26% (excluding gaps); considering only the region 
modelled, the identity is 28%. The alignment is similar 
to that previously based on the primary structures [6] 
and similarities with the NADP’-linked enzyme [ 11, ex- 
cept that gaps and insertions are now placed outside 
elements of secondary structure. Residues that are con- 
served in most short-chain dehydrogenases are con- 
served also in this alignment. 
Alignment of the first 189 residues (through /IF) pre- 
sented no special problems, However, alignment be- 
yond /YF is difficult because there are few conserved 
residues in the remaining parts. The next element of 
secondary structure in 3a/20/3-hydroxysteroid dehydro- 
genase, the helix aG (Met189-Ty?02), can be aligned 
with either Ile’90-Tyr203 of the NAD’-linked prosta- 
glandin dehydrogenase or shifted toward the C-termi- 
nus of the prostaglandin dehydrogenase. We chose the 
latter alternative, introducing a loop between j3F and 
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Fig. 1. Alignment (A) of NAD’-dependent prostaglandin dehydrogenase with 3cr/20jShydroxysteroid dehydrogenase, and schematic representation 
(B) of the two prostaglandin dehydrogenases and the steroid dehydrogenase. In A, residue identities are boxed. Elements of secondary structure 
crystallographically determined in the steroid dehydrogenase [7] are shown above the sequence line. Positional numbers of each enzyme are given. 
Up to residue 189 of the prostaglandin dehydrogenase, alignments are considered final, the remaining parts more tentative. In the latter segments, 
supporting evidence for the alternative shown is given in the text. The choice of the position of aG gives a 33-residue xtra loop in the prostaglandin 
dehydrogenase vs. the steroid dehydrogenase, as shown. In B, NAD’-linked (top) and NADP’-linked (bottom) dehydrogenases are given 
schematically relative to the 3&20/I-hydroxysteroid dehydrogenase (middle) determined crystallographically. 
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aG in the prostaglandin dehydrogenase (Fig. 1) because 
limited proteolysis of two different short-chain dehy- 
drogenases results in cleavages in just this segment [161. 
This suggests that the segment occupies a surface posi- 
tion on the enzyme molecule, as is commonly observed 
for inserted loops. Further, it makes the structure simi- 
lar in this segment o that of another member of the 
short-chain dehydrogenase family, dihydropteridine re- 
ductase, which has also been crystallographically ana- 
lyzed [8]. In the model, the aG helix would start at either 
Hiszo9 or Pro223. Secondary structure predictions do not 
help to decide between these two alternatives since 
stretches of a-helices are predicted for both segments. 
We chose the latter alternative, aligning Met’89-Tyr202, 
aG in 3a/20/3-hydroxysteroid ehydrogenase, with 
Pro223-Asp236 in the NAD’-linked 15hy-droxyprosta- 
glandin dehydrogenase. We have not modelled the 33 
residues between BF and aG (residues 190-222) or the 
last 17 residues of the protein chain (after position 248). 
The C-terminal part of the prostaglandin dehydroge- 
nase is slightly longer than that of the steroid dehydro- 
genase and may contain an additional antiparallel /3- 
strand similar to the one present in dihydropteridine 
dehydrogenase [8]. 
The alignment obtained has one long insertion to- 
ward the steroid dehydrogenase. Significantly, the 
NADP’-linked prostaglandin dehydrogenase previ- 
ously modelled also has a long insertion [l] (Fig. IB). 
The two prostaglandin dehydrogenases modelled ([l] 
and this work), and the steroid dehydrogenase [7] and 
dihydropteridine reductase [8] crystallographically ana- 
lyzed, establish a conserved, coenzyme-binding, N-ter- 
minal part, with parallel /?-sheets and flanking a-helices, 
continuing into a highly variable C-terminal region that 
imparts distinct properties to individual members of the 
Fig. 2. A stereoview of the modelled three-dimensional structure of 
dimeric 1Shydroxyprostaglandin dehydrogenase. The trace of the 
cc-carbon atoms are shown in solid lines for one subunit and dashed 
lines for the other. Amino acid side chains shown (bold) are at the 
active site; numbers 1 and 248 show the a-carbons of the first and last 
residues modelled. The view is nearly along the molecular two-fold 
axis relating the subunit association through the a-helices, aE and aF, 
at the Q axis interface. The unmodelled segment, residues 19C-222, is 
not shown, explaining the loose ends (middle right in the dashed 
subunit). 
Fig. 3. A close-up stereoview of the catalytic site in modelled 15- 
hydroxyprostaglandin dehydrogenase. The two subunits are drawn in 
solid and dashed lines as traces of their a-carbon atoms. Side chains 
shown (bold) are: Thr”, G1n15, Trp”, Asn”, Ser’38, Tyr”‘, and LYS”~. 
short-chain dehydrogenase family. The model of the 
NAD’-linked prostaglandin dehydrogenase dimer is 
shown in Fig. 2. The residues making up the /?-strands 
are more highly conserved with respect to the steroid 
dehydrogenase (50% identity, 8 1% conserved polarity) 
than other parts of the sequence. This is consistent with 
the B-sheet being internal, while a-helices and loops are 
on the surface and therefore more tolerant to variation. 
3.2. Active site residues 
Many residues that are conserved in almost all short- 
chain dehydrogenases [6] are close to, or in the active 
site of, the steroid dehydrogenase [7], and are conserved 
also in the prostaglandin dehydrogenase model, i.e. 
Thr”, Gly12, Asn”, Ala92, Gly93, Ser13*, Tyr”‘, Lys”‘, 
Prolx3, G~Y’*~ and ASHES. 
Residues that interact with the coenzyme in the ster- 
oid dehydrogenase [7] and corresponding residues in the 
prostaglandin dehydrogenase model (within parenthe- 
ses) are: Asp3’ (ASHES), Thr12 (Thr”), Arg16 (Gin”), 
Ile”’ (GIY”~), Trp6’ (Leu”), Ile”’ (Tyr12’), Asplo 
(Ser’13) and Gl# (Glnj9). Although only two of these 
residues are strictly conserved, all except one have con- 
served polarity. Other residues in the coenzyme-binding 
pocket are Trp3’, Val”, and Met12*. 
The inner part of the prostaglandin dehydrogenase 
substrate binding pocket is hydrophilic with many polar 
residues: Asn”, Tyr”‘, Lys”‘, Ser13’, Gln15 Asn95, 
Gln14*, G1u9’ and Asn”‘. The outer part of the pocket 
is more hydrophobic, with Va1’45, Prols3, Phe”‘, Leu’39, 
Met’43 Alal and Val”‘. Positions of important resi- 
dues at the active sites of the dimer are shown in 
Fig. 3. 
3.3. Subunit-subunit interactions 
The NAD’-linked prostaglandin dehydrogenase is a 
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Fig. 4. A stereoview of the subunit interface of modelled 15-hy- 
droxyprostaglandin dehydrogenase, viewed nearly parallel to the Q 
axis. The interface is comprised primarily of helices aE’s (top layer) 
and aF’s (partially visible; bottom layer), in a four-helix bundle. Side 
chains shown at the interfacial surface are Gin’” and Lys’” (from ccE), 
and Gly15’ and Phe16i (dF). Small residues (Gly and Ala) in aF permit 
the close packing of these two helices. 
dimer, while the crystallographically analyzed 3a/20/% 
hydroxysteroid dehydrogenase is a tetramer with sub- 
units related by a set of three mutually perpendicular 
rotation axes (Q, P and R). The most extensive contacts 
are those related by the Q axis and involve two helices, 
aE and aF. In our prostaglandin dehydrogenase model, 
these two helices have hydrophobic surfaces that could 
well contribute to the stabilization of dimer formation 
across the face as illustrated in Fig. 2. An alternative 
model for dimer formation would involve association 
about the P rotation axis which relates faces that con- 
tain the hydrophobic surfaces of aG but are otherwise 
less suited to dimer formation over their entire surface. 
The compatability of association of the hydrophobic 
side-chains of aE and aF is illustrated in Fig. 4. Specif- 
ically, internal hydrophobic interactions (Tyr’16 with 
Tyr’16, Leu”’ with Ile112, AlaIs with Glyla, Gly15’ with 
Gly15’, and Phe16’ with Pro14’, Trp’OO) and polar interac- 
tions closer to the edges of the helices (Asp12’, LYS’~~ 
with Gin”‘, and SerlM with His156) would stabilize the 
dimer formation about the Q axis. In this dimer, the 
active sites contain residues from only one of the two 
subunits. 
3.4. Conclusion 
The present modelling of NAD’-linked prosta- 
glandin dehydrogenase, together with the crystallogra- 
phic analyses of 3al20/I-hydroxysteroid ehydrogenase 
[7] and dihydropteridine reductase [8], and the mod- 
elling of the NADP+-linked dehydrogenase [ 11, establish 
common properties of the short-chain dehydrogenases: 
(i) The structures, although exhibiting residue identi- 
ties only at the 20% level, are clearly related in tertiary 
structure, and have single domain architectures and 
similar active site topologies. 
(ii) Toward the C-terminal parts some organiza- 
tional differences occur, with insertions or deletions of 
long segments as observed in both the crystallographi- 
tally determined enzyme pair [7,8] and the two prosta- 
glandin dehydrogenases (Fig. 1B). 
(iii) In the oligomerization of these enzymes, major 
subunit interactions seem to be conserved, the face of 
the monomer containing the aE + aF helices appar- 
ently capable of forming stable subunit interactions in 
both the tetrameric and dimeric enzymes, highlighting 
the importance of the Q axis and suggesting that subunit 
interactions are possible to predict in this group of en- 
zymes. 
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